# A Clinical Study of CHT102 in Mesothelin Positive Advanced Solid Tumors

> **NCT06717022** · NA · RECRUITING · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 24 (estimated)

## Conditions studied

- Mesothelin Positive Tumors

## Interventions

- **BIOLOGICAL:** CHT102 allogeneic CAR T cells

## Key facts

- **NCT ID:** NCT06717022
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-06
- **Primary completion:** 2026-06
- **Final completion:** 2039-05
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2024-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06717022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06717022, "A Clinical Study of CHT102 in Mesothelin Positive Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06717022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*